Bublish empowers entrepreneurial authors with the technology, tools, programs and resources they need to achieve success. The Bublish platform is the first complete cloud-based publishing system with integrated marketing, branding, and discoverability features. Thousands of authors and publishers around the world use Bublish to write, promote, publish, sell and track their work—all from their Bublish dashboard.
Bublish empowers entrepreneurial authors with the technology, tools, programs and resources they need to achieve success. The Bublish platform is the first complete cloud-based publishing system with integrated marketing, branding, and discoverability features. Thousands of authors and publishers around the world use Bublish to write, promote, publish, sell and track their work—all from their Bublish dashboard.
CadChat was acquired by GoEngineer in 2025.
CadChat makes it possible for everyone to easily share, view and provide feedback on any 3D model design. An approachable user experience presents powerful design collaboration tools for asynchronous reviews or real time huddles.
CadChat was acquired by GoEngineer in 2025.
CadChat makes it possible for everyone to easily share, view and provide feedback on any 3D model design. An approachable user experience presents powerful design collaboration tools for asynchronous reviews or real time huddles.
Carputty is auto financing, reinvented. Carputty allows people to fund their vehicles, now and down the road, and manage them like the investments they are.
Carputty is auto financing, reinvented. Carputty allows people to fund their vehicles, now and down the road, and manage them like the investments they are.
Cirtmeo was acquired by Thorlabs in 2019.
Cirtemo's Multivariate Optical Element (MOE) platform allows optical systems manufacturers to tackle new high-value applications that are not possible with traditional optical filters and coatings.
Cirtmeo was acquired by Thorlabs in 2019.
Cirtemo's Multivariate Optical Element (MOE) platform allows optical systems manufacturers to tackle new high-value applications that are not possible with traditional optical filters and coatings.
Confidence is a curly girls hair accessory solutions brand founded by seven-year-old GaBBY Bows Inventor Gabby Goodwin and her mom Rozalynn Goodwin.
Confidence is a curly girls hair accessory solutions brand founded by seven-year-old GaBBY Bows Inventor Gabby Goodwin and her mom Rozalynn Goodwin.
DART was acquired by Quad in 2024.
DART are full-service partners who leverage dynamic digital technology – anchored in our history in retail, a deep understanding of the CPG landscape, and experience in advertising – to help brands and retailers maximize their visibility and drive revenue growth.
DART was acquired by Quad in 2024.
DART are full-service partners who leverage dynamic digital technology – anchored in our history in retail, a deep understanding of the CPG landscape, and experience in advertising – to help brands and retailers maximize their visibility and drive revenue growth.
Ecomdash was acquired by Endurance International Group in 2019.
Ecomdash is a software solutions provider that enables inventory management, distribution, and multichannel marketplace listings for ecommerce retailers.
Ecomdash was acquired by Endurance International Group in 2019.
Ecomdash is a software solutions provider that enables inventory management, distribution, and multichannel marketplace listings for ecommerce retailers.
Cloud-based SaaS platform that tracks maintenance tasks and quality control for all your lab instruments.
Cloud-based SaaS platform that tracks maintenance tasks and quality control for all your lab instruments.
Emergo Therapeutics is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. A vast majority of these conditions are not treated with mast cell therapies, even though overwhelming evidence shows this would be therapeutically beneficial. Emergo’s therapeutic interventions are focused on reducing the production of inflammatory cytokines from mast cells.
Emergo Therapeutics is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. A vast majority of these conditions are not treated with mast cell therapies, even though overwhelming evidence shows this would be therapeutically beneficial. Emergo’s therapeutic interventions are focused on reducing the production of inflammatory cytokines from mast cells.
FarmShots was acquired by Syngenta in 2018.
FarmShots detects diseases, pests, and poor plant nutrition on farms by analyzing satellite and drone imagery.
FarmShots was acquired by Syngenta in 2018.
FarmShots detects diseases, pests, and poor plant nutrition on farms by analyzing satellite and drone imagery.